Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MorphoSys AG Board/Management Information 2002

May 7, 2002

291_rns_2002-05-07_4907509e-090e-4d64-bdcf-a94d9cb7f680.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

News Details

Corporate | 7 May 2002 08:03

MorphoSys AG english

MorphoSys Appoints General Counsel and Corporate Communications Manager Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– MorphoSys Appoints General Counsel and Corporate Communications Manager MorphoSys AG (Neuer Markt: MOR) announced the appointments of Dr. Claudia Gutjahr-Löser to the post of Manager Corporate Communications and Dr. Alexander Oehmichen to the post of General Counsel. Dr. Gutjahr-Löser joins MorphoSys from cassiopeia AG, where she held the positions of Investor Relations Manager and Assistant to the C.E.O. At cassiopeia AG she played an instrumental role in organizing financing rounds and her role outside of investor relations including responsibilities for the human resources and legal functions. Prior to this position, she worked at Deutsche Bank in various capacities. Dr. Gutjahr-Löser holds an Ph.D. in Biology from the University of Munich. In the role of this newly created position, she will report to Dave Lemus, Chief Financial Officer of MorphoSys, and be primarily responsible for European corporate communications. Prior to joining MorphoSys, Dr. Oehmichen held several management positions in pharmaceutical companies such as Boehringer Mannheim GmbH (Germany) and Knoll AG (Germany), where he acquired extensive experience in business law. In his most recent position at Abbott GmbH & Co. KG, he headed the legal department, counseling and guiding the management in all legal implications of corporate strategy and policies. He was also responsible for negotiating all major agreements, with emphasis on the areas of merger and acquisitions, strategic licenses and alliances. In his new position at MorphoSys, Dr. Oehmichen will report to Dr. Simon Moroney, Chief Executive Officer of MorphoSys. end of message, (c)DGAP 07.05.2002